nephrogenic systemic fibrosis (nsf) and gadolinium-based contrast media
Clicks: 229
ID: 130578
2013
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Popular Article
30.0
/100
228 views
22 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Nephrogenic systemic fibrosis (NSF), unknown before March 1997 and first described in 2000, is a systemic disorder characterised by widespread tissue fibrosis. The first known case occurred in 1997, after the use of gadolinium-based contrast agents (GBCAs) at high doses in patients with renal failure had become routine. An overwhelming majority occurred within weeks to months after injection of a GBCA. This note comprises guidelines on the prevention of NSF.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (67 words).
Try re-searching for a better abstract.
| Reference Key |
ngoya2013southnephrogenic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;P.S. Ngoya;Z Vawda;J.W Lotz |
| Journal | annales pharmaceutiques francaises |
| Year | 2013 |
| DOI |
10.4102/sajr.v17i3.277
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.